This Is How Much Berkshire Hathaway Made From Coca-Cola and American Express Dividends in 2025 Alone

Berkshire earned $816M from Coca-Cola and $479M from American Express dividends in 2025, with current position market values of roughly $56B (Coca-Cola) and $28B (American Express). Berkshire's yield on cost is extremely high: Coca-Cola pays $2.12 annually versus Berkshire's $3.25 cost basis per share (~65% yield on cost) and American Express pays $3.80 on an $8.60 cost basis (~44% yield on cost). Abel highlighted these holdings (plus Apple and Moody's, the latter ~42% yield on cost) as long-term compounders and signaled continuity with Buffett's strategy, underscoring dividend income's strategic value for acquisitions and operations.

Analysis

Berkshire’s low-turnover, dividend-funded flywheel creates optionality that isn’t priced into peers: predictable cash from mature franchises funds acquisitions with near-zero market-sentiment friction, which reduces forced selling in downturns and compresses free float for those names. That structural scarcity amplifies long-term returns for holders but also concentrates balance-sheet risk — a large acquisition need would be the fastest path to realize paper gains and could create a sudden, correlated supply shock in KO/AXP-like names.

Second-order winners include high-quality service franchises exposed to recurring revenue (ratings, payments, exchanges) because dividend cashflow favors owning stable-EBITDA businesses; second-order losers are cyclical consumer and bank lenders who depend on volatile deposit/credit cycles and whose buyback-heavy returns can underperform over a full credit cycle. Input-cost or regulatory shocks to consumer staples or charge-off spikes in card portfolios are the proximate catalysts that can reverse the “dividend compounding” narrative over 6-24 months.

Risk framing: the primary tail risks are (1) a consumer-credit shock that forces dividend cuts at card issuers, (2) a strategic need at Berkshire to monetize concentrated stakes to fund a transformational purchase, and (3) secular demand erosion in sugary beverages accelerated by regulation. These play out on different timelines — credit and regulation can move within quarters, while management-driven monetization is event-driven and could materialize on days-to-weeks.

Contrarian inference: the market treats yield-on-cost as an evergreen advantage, but it masks opportunity cost and governance friction — high yield-on-cost can create perverse incentives to under-allocate into faster-growing secular winners (e.g., AI-exposed semiconductors). If a macro shock forces realization of embedded gains, we should expect multi-week dislocations in high-conviction legacy holdings rather than a slow, orderly rerating.

Key Decisions for Investors

• Buy KO 24–36 month call LEAPS (delta ~0.30–0.40) financed by selling 3–6 month covered calls on sizeable lots — time horizon 12–36 months. R/R: asymmetric upside if brand pricing power holds (target 20–40% IRR) with premium financing cutting cost basis; downside limited to net premium plus short-call assignment risk.
• Long MCO outright for 6–12 months (or buy a 9–12 month call spread) to play durable ratings revenue and higher-for-longer rates; target 15–25% upside vs S&P in a rate-stable scenario. Hedge tail risk with a 10–12 month 5–7% OTM put to cap downside to a known cost.
• Protect AXP exposure with a 9–12 month put spread (buy 10–15% OTM put, sell cheaper further OTM put) sized to cover portfolio credit exposure — cost ~low single-digit % of notional. Rationale: preserves upside while capping drawdowns from a consumer credit shock; acts as cheap recession insurance.
• Overweight BRK.B selectively on any 5–12% market-driven weakness in bank/consumer names (time horizon 1–3 years). R/R: long-term optionality to benefit from both retained cash yields and disciplined M&A; set stop if broader financial stress spikes credit spreads >200bps vs median.